These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6214758)

  • 1. [Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
    Mouton Y; Beaucaire G; Caillaux M; Deboscker Y; Fourrier A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):495-500. PubMed ID: 6214758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].
    Gonzenbach HR; Sonnabend W
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1169-83. PubMed ID: 6456543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam for treatment of nosocomial infections.
    Winston DJ; Kurtz TO; Young LS; Busuttil RW
    Rev Infect Dis; 1982; 4 Suppl():S650-S655. PubMed ID: 6218578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of moxalactam].
    Acar JF
    Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
    Hautmann R; Pranada F; Ahlert G
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of septicemia with latamoxef. Multicentric study of 60 cases].
    Salord JC; Armengaud M; Aubertin J; Bertrand A; Carbon C; Dureux JB; Goulon M; Gouin F; Leng B; Motin J; Mouton Y; Portier H; Veyssier P
    Ann Fr Anesth Reanim; 1982; 1(6):655-60. PubMed ID: 6224444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aztreonam in the therapy of nosocomial infections in patients with impaired host defenses.
    Cristiano P; Iovene MR; Paradisi F
    Chemioterapia; 1985 Apr; 4(2):182-5. PubMed ID: 3891117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM; Del Bene VE; Burkey LG; Collins CD; Richmond DK
    Rev Infect Dis; 1982; 4 Suppl():S683-7. PubMed ID: 6218583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.